Dr. Christian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
460 W 10th Ave
5th Floor
Columbus, OH 43210Phone+1 614-293-3196Fax+1 614-293-4812- Is this information wrong?
Education & Training
Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2006 - 2009- Ohio State University HospitalResidency, Internal Medicine, 2002 - 2005
- Ohio State University College of MedicineClass of 2002
Certifications & Licensure
OH State Medical License 2002 - 2025- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma Start of enrollment: 2009 Sep 01
- A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma Start of enrollment: 2011 Oct 13
- Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma Start of enrollment: 2012 Feb 09
- Join now to see all
Publications & Presentations
PubMed
- Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in the United States: a real-world analysis.Epperla, N., Narendranath Epperla, Qiuhong Zhao, Tamara Moyo, Marcus P Watkins, Montreh Tavakkoli, Celeste Bello, Pallawi Torka, Nishitha Reddy, Colin Thomas, Kaitlin ...> ;Blood Advances. 2024 Feb 13
- Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study.Kaitlin Annunzio, Natalie S Grover, Rina Li Welkie, Pallawi Torka, Marcus P Watkins, Andrea Anampa-Guzmán, Montreh Tavakkoli, Timothy S Oh, Heather Reves, Daniel Jones...> ;Blood Advances. 2023 Nov 28
- A cancer disparities curriculum in a hematology/oncology fellowship program.Marium Husain, Muhammad Salman Faisal, Dionisia Quiroga, Audrey M Sigmund, Gregory Otterson, Alison Walker, Samilia Obeng-Gyasi, Beth Christian> ;BMC Medical Education. 2023 Oct 17
- Join now to see all
Abstracts/Posters
- Brentuximab Vedotin and Nivolumab for Relapsed or Refractory Classic Hodgkin Lymphoma: Long-Term Follow-up Results from the Single-Arm Phase 1/2 StudyBeth A. Christian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Brentuximab Vedotin (BV) and Lenalidomide (Len) in Relapsed and Refractory (r/r) Cutaneous (CTCL) and Peripheral (PTCL) T-Cell Lymphomas; A Planned Interim Analysis of...Beth A. Christian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- A Phase I Study of Nivolumab and Lenalidomide in Relapsed/ Refractory B Cell LymphomaBeth A. Christian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Results of a Phase I Study of Obinutuzumab, Venetoclax, and Lenalidomide in Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Pembrolizumab in Patients with Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL): Data from the Keynote-013 and Keynote-170 StudiesClinically Re...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Phase 1/2 Study of Brentuximab Vedotin in Combination with Nivolumab in Patients with Relapsed or Refractory Classic Hodgkin Lymphoma: Part 3 (Concurrent Dosing) Resul...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Hospital Affiliations
Ohio State University Wexner Medical CenterColumbus, Ohio
The OSUCCC - JamesColumbus, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
